Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
China Life Insurance Co ( (HK:2628) ) has shared an update.
China Life Insurance Company Limited has released its solvency quarterly report for the third quarter of 2025, prepared under the guidelines of the National Financial Regulatory Administration. This report reflects the company’s adherence to regulatory standards and provides insights into its financial health, which is crucial for maintaining stakeholder confidence and ensuring continued operations within the competitive insurance market in China.
The most recent analyst rating on (HK:2628) stock is a Buy with a HK$31.00 price target. To see the full list of analyst forecasts on China Life Insurance Co stock, see the HK:2628 Stock Forecast page.
More about China Life Insurance Co
China Life Insurance Company Limited is a major player in the insurance industry in the People’s Republic of China, offering life, health, accident, and personal insurance services. The company also engages in reinsurance, funds management, and securities investment fund sales, operating within the regulatory framework set by national authorities.
Average Trading Volume: 76,790,120
Technical Sentiment Signal: Buy
Current Market Cap: HK$1217B
For an in-depth examination of 2628 stock, go to TipRanks’ Overview page.